Dermatology Trials

Make derm endpoints usable before the visit.

Delve runs the between-visit operating model: topical routines, symptom capture, and standardized photography—backed by concierge follow-through and live oversight—so missingness gets resolved early, not explained later.

Dermatology studies live and die between visits: topical adherence, flare timing, itch and pain capture, standardized photography, and consistent assessment routines. Delve combines CRO-style execution with a real-time compliance operating model—eCOA/ePRO, photo workflows, concierge follow-through, kit logistics, and live oversight— so you get usable evidence, not just collected data.

Atopic Dermatitis Psoriasis Hidradenitis Suppurativa Acne Vitiligo Alopecia

Between-visit adherence

Owned

Topicals, diaries, photo cadence

Data quality

Live

Photo QC + missingness alerts

Site burden

Lower

Concierge absorbs follow-up load

Dermatology trial evidence chain showing photo capture, ePRO symptoms, quality gates, interventions, and usable endpoints

Designed for dermatology realities

More than a platform—an operational model that protects the endpoint.

Dermatology success depends on consistency between visits. Delve enforces imaging standards, supports adherence routines, and rescues missingness before it becomes a protocol deviation.

Abstract visualization representing photo capture quality control

Photo QC & re-capture loops

Quality gates for lighting, framing, and consistency—plus re-capture prompts before unusable images spread.

Abstract visualization representing adherence operations and reminders

Between-visit adherence operations

Topical routines, diaries, and symptom capture reinforced by reminders and human follow-through.

Abstract visualization representing reduced site burden and proactive support

Lower site burden

Concierge handles participant training, troubleshooting, and rescheduling—so coordinators can focus on assessments.

Why Delve

Derm trials are not “visit-managed.” They are behavior-managed.

In dermatology, the evidence chain breaks through routine friction: topicals are skipped, photos are inconsistent, symptoms go unreported, and flare timing is missed. Delve closes these gaps by owning adherence operations and documenting interventions—continuously, not retrospectively.

Traditional CRO

Strong at visit cadence

  • Monitoring and reporting structure
  • Site communication and oversight
  • Standardized processes and templates
  • Issue escalation after findings emerge

Risk: derm adherence and photo quality degrade between visits; issues are discovered late and fixed expensively.

CRO + point tools

More tools, more failure points

  • Separate vendors for ePRO, imaging, reminders, logistics
  • Disconnected data streams and unclear accountability
  • Sites absorb follow-up, re-training, re-capture
  • Data QC happens after weeks of drift

Risk: “missingness” becomes the story, not the endpoint.

Delve delivery model

Owned compliance + owned photo quality

  • Real-time adherence visibility (topicals, diaries, photos)
  • Concierge team intervenes when drift appears
  • Photo QC rules + re-capture loops before visits
  • Evidence trails: what happened, actions taken, outcome

Outcome: higher usable data yield, fewer protocol deviations, lower site burden, stronger retention.

Dermatology Evidence Chain

Standardized imaging + symptoms + interventions = usable endpoints.

Dermatology endpoints are especially sensitive to between-visit variability. Delve closes the loop with quality gates, real-time alerts, and documented interventions when the chain breaks.

Photo Capture ePRO Symptoms QC Quality gates Alert Intervene Endpoint Usable data
Photo QC: lighting, framing, angle, consistency, re-capture triggers
Symptom capture: itch/pain/sleep, flare timing, treatment burden
Interventions: concierge coaching, rescheduling, re-training, escalation pathways

How We Engage

Flexible models—from prime execution to CRO integration.

Full-Service Dermatology Delivery (Prime)

Delve leads execution end-to-end with a derm operating model built around adherence, imaging quality, and real-time oversight. Specialty functions can be delivered directly or through Delve-led partners as scoped.

  • Start-up + site coordination
  • Patient operations + concierge follow-through
  • eCOA/photo/logistics + live quality control

Hybrid With Your CRO

Keep your CRO for monitoring/EDC and plug Delve in as the compliance, imaging, and participant operations layer. We reduce missingness, improve photo consistency, and provide live risk visibility.

  • Delve owns adherence operations and patient support
  • Photo QC + re-capture + escalation pathways
  • Cleaner datasets at lock with fewer late-cycle fixes

Site Network Enablement

We offload the most time-consuming derm follow-up work—topical reminders, diary completion, photo coaching, and re-capture—so sites can focus on assessments and enrollment.

  • Coordinator relief: reminders, training, rescheduling
  • Patient coaching for consistent at-home photos
  • Study-wide oversight dashboards for networks

Live Metrics (Example)

What sponsors and study teams see in Delve.

These are example visuals to demonstrate how we monitor adherence, imaging quality, and completion trends in real time. Your study’s dashboards reflect your protocol, schedules, and site structure.

Adherence trend with interventions

Markers indicate documented interventions (coaching, re-training, rescheduling) that prevent drift.

Photo QC pass rate

Quality gates surface low-confidence images early, enabling re-capture within protocol windows.

Task completion by site

Sites with higher friction get proactive concierge support and targeted retraining workflows.

Protocol-to-Analysis

End-to-end dermatology delivery—mapped to real failure points.

“End-to-end” means ownership with evidence trails—from protocol operationalization and imaging standards through compliance rescue, data QC, and analysis readiness.

Step 1

Protocol operationalization

  • SOA converted into executable tasks and visit windows
  • Derm risk register: adherence, imaging, flare timing
  • Intervention rules + escalation pathways defined
Delve-owned

Step 2

Imaging & assessment standards

  • Photo capture SOPs and participant coaching plan
  • Quality gates: lighting, framing, reference markers
  • Re-capture workflows before endpoint drift spreads
Delve-owned

Step 3

Feasibility + site enablement

  • Site/network strategy aligned to indication and burden
  • Start-up coordination and readiness tracking
  • Training workflows for coordinators and investigators
Delve-led

Step 4

Onboarding + compliance setup

  • Topical routines, diary schedules, and reminders configured
  • Patient training: photos, symptom capture, supplies
  • Multilingual concierge support for ongoing questions
Delve-owned

Step 5

Conduct: adherence operations

  • Real-time task adherence monitoring (topicals/diaries/photos)
  • Concierge outreach when compliance drifts
  • Documented interventions + outcomes (audit-ready)
Delve-owned

Step 6

Safety & symptom escalation

  • Protocol-driven triggers for worsening symptoms/AE signals
  • Structured routing to site/sponsor teams
  • Evidence trails of follow-up actions and closure
Integrated

Step 7

Data quality + reconciliation

  • Missingness surveillance across ePRO and imaging
  • Photo QC exceptions tracked and resolved
  • Reconciliation across sources and exports (as scoped)
Delve-led

Step 8

Analysis readiness + close-out

  • Analysis-ready exports and documented handling rules
  • Close-out package: adherence summary + QC outcomes
  • Support for interim looks and endpoint performance review (as scoped)
Delve-led

Dermatology Capabilities

Execution built for dermatology realities.

Topical adherence is the endpoint risk

Derm efficacy signals are sensitive to dosing routines, washout rules, and daily behavior—not just site visits.

  • Protocol-driven dosing diaries and reminders
  • Human follow-through when adherence drifts
  • Documented deviations + rescue actions with timestamps

Imaging workflows that prevent unusable photos

Low-quality at-home photos silently corrupt endpoints. We enforce capture standards before data is lost.

  • Guided capture instructions + coaching scripts
  • Quality gates (lighting, distance, angle, framing)
  • Re-capture loops and escalation to sites when needed

Symptom capture that matches flare reality

Itch, pain, sleep disruption, and flare timing need consistent capture—without adding workload to sites.

  • ePRO schedules for itch, pain, sleep, QoL, flare events
  • Concierge outreach for missed entries and confusion
  • Site relief: fewer calls, fewer late diary reconciliations

Deliverables

What you receive when Delve runs dermatology execution.

  • Operational study plan + dermatology execution risk register
  • Participant adherence plan: topicals/diaries/photo cadence + scripts
  • Imaging SOP: capture standards, QC rules, re-capture workflow
  • Data quality plan: missingness rules, QC checks, reconciliation approach
  • Weekly risk report: adherence, retention, imaging quality, site/network performance
  • Close-out evidence package: intervention logs, adherence summary, QC outcomes

From patient behavior to analysis-ready evidence

Derm studies don’t fail because the endpoint is unclear. They fail because the routine breaks. Delve operationalizes adherence, enforces imaging standards, and documents interventions—so your datasets are usable.

  • Continuous missingness surveillance across tasks and imaging
  • Documented interventions (what happened, when, why, outcome)
  • Reconciliation across digital sources and exports (as scoped)
  • Readiness support for interim looks and endpoint reviews (as scoped)

If you already have DM/biostats partners, Delve strengthens the operational evidence chain without replacing your stack.

Download

Post-Market Compliance Playbook (Sponsor Edition)

A practical operating model for long-term follow-up: how to detect compliance drift early, intervene fast, reduce site burden, and keep endpoints usable across eCOA + photos + wearables.

What’s inside

  • Between-visit compliance ownership model
  • Intervention workflows + escalation paths
  • Photo QC and re-capture governance

Who it’s for

  • Clinical Operations
  • Medical Affairs / Post-Approval
  • RWE / HEOR teams

Get it

Hook this to a HubSpot form embed.

Send me the Playbook

Or request a 15-min walkthrough.

Planning a dermatology study?

If your endpoints depend on consistent behavior between visits—topicals, diaries, photos, flare reporting—Delve is built to protect that evidence chain. We can lead end-to-end execution or integrate with your CRO to improve compliance and retention.

FAQ

Dermatology trial compliance: common questions

The failure points that quietly break derm endpoints: photos, symptoms, adherence, and between-visit drift.

How do you standardize at-home dermatology photography?

We enforce capture standards (lighting, framing, distance, angle, reference markers) and use quality gates plus re-capture loops so unusable photos are corrected inside protocol windows—not discovered at the visit or at lock.

Why do derm studies lose compliance between visits?

Derm endpoints depend on daily routines: topical adherence, symptom capture, and photo cadence. Drift starts small and compounds. Without an operating model that intervenes early, missingness becomes normalized.

Does eCOA alone solve derm compliance?

eCOA can capture tasks and generate alerts, but it doesn’t guarantee recovery. Delve pairs real-time monitoring with concierge follow-through to resolve missed entries, confusion, and device friction in hours—not weeks.